A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma

Journal of the National Cancer Institute

Volumn 98, Issue 12, 2006, Pages 825-838

  Tsai, Meng Feng ^a,b,c   Wang, Chi Chung ^b   Chang, Gee Chen ^d,e   Chen, Chih Yi ^d   Chen, Hsuan Yu ^b   Cheng, Chiou Ling ^a,b   Yang, Yu Ping ^a,b   Wu, Chun Yi ^b   Shih, Fu Yuan ^a,b,f   Liu, Chun Chi ^f   Lin, Hsiu Ping ^b   Jou, Yuh Shan ^g   Lin, Shu Chen ^g   Lin, Chung Wu ^a   Chen, Wei J ^b   Chan, Wing Kai ^a   Chen, Jeremy J W ^b,f   Yang, Pan Chyr ^a,b,g  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^d TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^g INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; DNAJ LIKE HEAT SHOCK PROTEIN; INTERFERON; PROTEIN P53; STAT1 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOMA CELL; CELL CYCLE PROGRESSION; CELL GROWTH; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; CHROMOSOME 1P; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA MICROARRAY; GENE LOCUS; GENE MAPPING; GENE OVEREXPRESSION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LOG RANK TEST; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALIDATION PROCESS; WESTERN BLOTTING;

BLOTTING, NORTHERN; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HSP40 HEAT-SHOCK PROTEINS; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MICROSATELLITE REPEATS; NEOPLASM RECURRENCE, LOCAL; ODDS RATIO; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; STAT1 TRANSCRIPTION FACTOR; SURVIVAL ANALYSIS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL;

EID: 33745243337     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djj229     Document Type: Article

References (50)

1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37:S4-66.
2. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47.
3. Hoffman PC, Mauer AM, Vokes EE. Lung cancer. Lancet 2000;355: 479-85.
4. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-7.
5. Naruke T, Goya T, Tsuchiya R, Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988;96:440-7.
6. Herbst RS, Yano S, Kuniyasu H, Khuri FR, Bucana CD, Guo F, et al. Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma. Clin Cancer Res 2000;6:790-7.
7. Moldvay J, Scheid P, Wild P, Nabil K, Siat J, Borrelly J, et al. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma. Clin Cancer Res 2000;6:1125-34.
8. Beer DG, Kardia SL, Huang CC, Giordano TJ, Levin AM, Misek DE, et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 2002;8:816-24.
9. Chen JJW, Peck K, Hong TM, Yang SC, Sher YP, Shih JY, et al. Global analysis of gene expression in invasion by a lung cancer model. Cancer Res 2001;61:5223-30.
10. Shih JY, Yang SC, Hong TM, Yuan A, Chen JJW, Yu CJ, et al. Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells. J Natl Cancer Inst 2001;93:1392-400.
11. Shih JY, Tsai MF, Chang TH, Chang YL, Yuan A, Yu CJ, et al. Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma. Clin Cancer Res. 2005;11:8070-8.
12. Hoe KL, Won M, Chung KS, Jang YJ, Lee SB, Kim DU, et al. Isolation of a new member of DnaJ-like heat shock protein 40 (Hsp40) from human liver. Biochim Biophys Acta 1998;1383:4-8.
13. Morimoto RI. Cells in stress: Transcriptional activation of heat shock genes. Science 1993;259:1409-10.
14. Jolly C, Morimoto RI. Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst 2000;92: 1564-72.
15. Csermely P, Schnaider T, Soti C, Prohaszka Z, Nardai G. The 90-kDa molecular chaperone family: Structure, function, and clinical applications. A comprehensive review. Pharmacol Ther 1998;79:129-68.
16. Kiang J, Tsokos G. Heat shock protein 70 kDa: Molecular biology, biochemistry, and physiology. Pharmacol Ther 1998;80:183-201.
17. Lindquist S, Craig EA. The heat shock proteins. Annu Rev Genet 1988;22:631-77.
18. Robert J. Evolution of heat shock protein and immunity. Dev Comp Immunol 2003;27:449-64.
19. Helmbrecht K, Zeise E, Rensing L. Chaperones in cell cycle regulation and mitogenic signal transduction: A review. Cell Prolif 2000;33:341-65.
20. Neininger A, Gaestel M. Evidence for a hsp25-specific mechanism involved in transcriptional activation by heat shock. Exp. Cell Res 1998;242: 285-93.
21. Kurzik-Dumke U, Gundacker D, Renthrop M, Gateff E. Tumor suppression in Drosophila is causally related to the function of the lethal (2) tumorous imaginal discs gene, a dnaJ homolog. Dev Genet 1995;16:64-76.
22. Schilling B, De-Medina T, Syken J, Vidal M, Munger K. A novel human DnaJ protein, hTid-1, a homolog of the Drosophila tumor suppressor protein Tid56, can interact with the human papillomavirus type 16 E7 oncoprotein. Virology 1998;247:74-85.
23. Canamasas I, Debes A, Natali PG, Kurzik-Dumke U. Understanding human cancer using Drosophila: Tid47, a cytosolic product of the Dnaj-like tumor suppressor gene 12Tid, is a novel molecular partner of patched related to skin cancer. J Biol Chem 2003;278:30952-60.
24. Chu YW, Yang PC, Yang SC, Shyu YC, Hendrix MJ, Wu R, et al. Selection of invasive and metastasic subpopulations from a human lung adenocarcinoma cell line. Am J Respir Cell Mol Biol 1997;17:353-60.
25. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987;47:3239-45.
26. Conway TF Jr, Sabel MS, Sugano M, Frelinger JG, Egilmez NK, Chen F, et al. Growth of human tumor xenografts in SCID mice quantified using an immunoassay for tumor marker protein in serum. J Immunol Methods 2000;233:57-65.
27. Bieche I, Onody P, Laurendeau I, Olivi M, Vidaud D, Lidereau R, et al. Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications. Clin Chem 1999;45:1148-56.
28. Chen JJW, Yao PL, Yuan A, Hong TM, Shun CT, Kuo ML, et al. Upregulation of tumor interleukin-8 expression by infiltrating macrophages: Its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. Clin Cancer Res 2003;9:729-37.
29. Shen CY, Yu JC, Lo YL, Kuo CH, Yue CT, Jou YS, et al. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: An implication for mutator phenotype and breast cancer pathogenesis. Cancer Res 2000;60:3884-92.
30. Tseng RC, Chang JW, Hsien FJ, Chang YH, Hsiao CF, Chen JT, et al. Genomewide loss of heterozygosity and its clinical associations in non small cell lung cancer. Int J Cancer 2005;117:241-7.
31. Chen HW, Yu SL, Chen JJW, Li HN, Lin YC, Yao PL, et al. Anti-invasive gene expression profile of curcumin in lung adenocarcinoma based on a high throughput microarray analysis. Mol Pharmacol 2004;65: 99-110.
32. Hong TM, Chen JJW, Peck K, Yang PC, Wu CW (2001). p53 Amino Acids 339-346 Represent the Minimal p53 Repression Domain. J Biol Chem 2001;276:1510-5.
33. Al-Mohanna MA, Al-Khodairy FM, Krezolek Z, Bertilsson PA, Al-Houssein KA, Aboussekhra A. p53 is dispensable for UV-induced cell cycle arrest at late G(1) in mammalian cells. Carcinogenesis 2001;22:573-8.
34. Nakai K, Horton P. PSORT: A program for detecting sorting signals in proteins and predicting their subcellulax localization. Trends Biochem Sci 1999;24:34-6.
35. Wang CC, Tsai MF, Hong TM, Chang GC, Chen CY, Yang WM, et al. The transcriptional factor YY1 upregulates the novel invasion suppressor HLJ1 expression and inhibits cancer cell invasion. Oncogene 2005;24:4081-93.
36. Yang ZY, Perkins ND, Ohno T, Nabel EG, Nabel GJ. The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo. Nat Med 1995;1:1052-6.
37. Kumar A, Commane M, Flickinger TW, Horvath CM, Stark GR. Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science 1997;278:1630-2.
38. Yu H, Jove R. The STATs of cancer - new molecular targets come of age. Nat Rev Cancer 2004;4:97-105.
39. Stephanou A, Latchman DS. STAT-1: A novel regulator of apoptosis. Int J Exp Pathol 2003;84:239-44.
40. Shivakumar L, Minna J, Sakamaki T, Pestell R, White MA. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol 2002;22:4309-18.
41. Benzeno S, Narla G, Allina J, Cheng GZ, Reeves HL, Banck MS, et al. Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1. Cancer Res 2004;64:3885-91.
42. Rocha S, Martin AM, Meek DW, Perkins ND. p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase 1. Mol Cell Biol 2003;23:4713-27.
43. Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 1993;7:812-21.
44. Willis A, Jung EJ, Wakefield T, Chen X. Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes. Oncogene 2004;23:2330-8.
45. Fearon ER. Human cancer syndromes: Clues to the origin and nature of cancer. Science 1997;278:1043-50.
46. Esteller M. CpG island hypermethylation and tumor suppressor genes: A booming present, a brighter future. Oncogene 2002;21:5427-10.
47. Girard L, Zochbauer-Muller S, Virmani AK, Gazdar AF, Minna, JD. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res 2000;60:4894-906.
48. Ragnarsson G, Eiriksdottir G, Johannsdottir JT, Jonasson JG, Egilsson V, Ingvarsson S. Loss of heterozygosity at chromosome lp in different solid human tumours: Association with survival. Br J Cancer 1999;79: 1468-74.
49. Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon JP, Vansteenkiste J, et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004; 350:351-60.
50. Chen KY, Chan CH, Yu CJ, Kuo SH, Yang PC. Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma. Cancer 2005;103:2566-74.